FORUM ITALICUM

该期刊的作者指南指出,作者应查阅其作者身份政策,其中包含作者资格标准、通讯作者人选等信息;并明确说明AI聊天机器人(例如ChatGPT)不应被列为作者。 模型中文摘要

Please view our authorship policies, which includes information on criteria for authorship, who should be the corresponding author and more. Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.

该期刊致力于促进研究的开放性、透明度和可重复性,鼓励作者在相关公共数据存储库中共享研究数据,并包含链接到数据的数据可用性声明;如果无法共享数据,应使用该声明确认无法共享的原因,并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

该期刊要求作者在指定标题下包含伦理批准声明,即使已在方法部分包含伦理批准信息;如果不需要伦理批准,必须明确说明。所有报告涉及人类参与者、人类数据或人体组织的研究的论文,必须声明相关伦理委员会或机构审查委员会批准了该研究,或豁免了批准要求,并提供审查委员会的全称和机构以及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

该期刊不收取提交或出版费用;提交的彩色图将在期刊在线版本中免费以彩色出版;对于特别要求的印刷版彩色复制,作者将在收到录用文章后收到Sage关于费用的信息;可选的开放获取出版可通过Sage Choice计划及开放获取协议付费进行,作者可根据与Sage的协议以折扣价或免费出版开放获取。 模型中文摘要

There are no fees payable to submit or publish in this journal. Figures submitted in color will be published in color in the online version of the journal at no cost. For specifically requested colour reproduction in print, you will receive information regarding the costs from Sage after receipt of your accepted article. Optional open access publishing is available for a fee via the Sage Choice pr…

该期刊采用双匿名同行评审流程,审稿人与编辑互动,不公布审稿信息;稿件将经过初步评估,如果不符合指南要求,将在同行评审前退回修改;如果超出期刊范围或以其他方式不合适,稿件可能在此阶段未经同行评审而被直接拒稿;通过初步评估后,稿件将进入同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: double anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

该期刊和Sage非常重视版权侵权、抄袭或其他违反出版最佳实践的问题,并请作者阅读Sage关于抄袭的完整政策及可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊接受已在预印本服务器上发布的稿件;作者在提交稿件时应在指定字段中输入预印本DOI,并建议在提交时告知期刊编辑部已发布的预印本;在同行评审期间,不应在预印本服务器上发布稿件的更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

该期刊认可ICMJE的要求,即临床试验应在首次招募参与者时或之前在WHO认可的公共试验注册机构注册;但与AllTrials运动一致,如果迟注册的理由可接受,将考虑回顾性注册的试验;试验注册机构名称和URL以及注册号必须包含在摘要末尾。 模型中文摘要

The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be …